<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: envelope protein</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Research advances therapy to protect against dengue virus</title>
   	 <description>Nearly half of the world's population is at risk of infection by the dengue virus, yet there is no specific treatment for the disease. Now a therapy to protect people from the virus could finally be a step closer, thanks to a team at MIT.</description>
     <link>http://medicalxpress.com/news/2013-04-advances-therapy-dengue-virus.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 08 Apr 2013 16:18:40 EST</pubDate>
	 <guid isPermaLink="false">news284656447</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/researchadva.jpg" width="90" height="90" />
</item>
<item>
     <title>Research reveals how antibodies neutralize mosquito-borne virus</title>
   	 <description>Researchers have learned the precise structure of the mosquito-transmitted chikungunya virus pathogen while it is bound to antibodies, showing how the infection is likely neutralized.</description>
     <link>http://medicalxpress.com/news/2013-04-reveals-antibodies-neutralize-mosquito-borne-virus.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 02 Apr 2013 12:37:59 EST</pubDate>
	 <guid isPermaLink="false">news284125062</guid>
	 
</item>
<item>
     <title>Research deciphers HIV attack plan</title>
   	 <description>(Medical Xpress)—A new study by Los Alamos National Laboratory and University of Pennsylvania scientists defines previously unknown properties of transmitted HIV-1, the virus that causes AIDS. The viruses that successfully pass from a chronically infected person to a new individual are both remarkably resistant to a powerful initial human immune-response mechanism, and they are blanketed in a greater amount of envelope protein that helps them access and enter host cells.</description>
     <link>http://medicalxpress.com/news/2013-04-deciphers-hiv.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Mon, 01 Apr 2013 09:38:43 EST</pubDate>
	 <guid isPermaLink="false">news284027912</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/researchdeci.jpg" width="90" height="90" />
</item>
<item>
     <title>Cell discovery could hold key to causes of inherited diseases</title>
   	 <description>Fresh insights into the protective seal that surrounds the DNA of our cells could help develop treatments for inherited muscle, brain, bone and skin disorders.</description>
     <link>http://medicalxpress.com/news/2013-02-cell-discovery-key-inherited-diseases.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 26 Feb 2013 11:39:36 EST</pubDate>
	 <guid isPermaLink="false">news281101152</guid>
	 
</item>
<item>
     <title>Experimental vaccine partially protects monkeys from HIV-like infection</title>
   	 <description>Results from a recent study show that novel vaccine combinations can provide partial protection against infection by Simian Immunodeficiency Virus (SIV) in rhesus monkeys. In addition, in the animals that became infected, the optimal vaccine combinations also substantially reduced the amount of virus in the blood. Results from the studies were published online today in the journal Nature.</description>
     <link>http://medicalxpress.com/news/2012-01-experimental-vaccine-partially-monkeys-hiv-like.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Wed, 04 Jan 2012 13:00:03 EST</pubDate>
	 <guid isPermaLink="false">news244898042</guid>
	 
</item>
<item>
     <title>Scientists reveal surprising picture of how powerful antibody neutralizes HIV</title>
   	 <description>Researchers at The Scripps Research Institute have uncovered the surprising details of how a powerful anti-HIV antibody grabs hold of the virus. The findings, published in Science Express on October 13, 2011, highlight a major vulnerability of HIV and suggest a new target for vaccine development.</description>
     <link>http://medicalxpress.com/news/2011-10-scientists-reveal-picture-powerful-antibody.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Thu, 13 Oct 2011 14:00:09 EST</pubDate>
	 <guid isPermaLink="false">news237732653</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/7-scientistsre.jpg" width="90" height="90" />
</item>
<item>
     <title>New HIV vaccine approach targets desirable immune cells</title>
   	 <description>Researchers at Duke University Medical Center, Beth Israel Deaconess Medical Center and Harvard Medical School have demonstrated an approach to HIV vaccine design that uses an altered form of HIV's outer coating or envelope protein.</description>
     <link>http://medicalxpress.com/news/2011-09-hiv-vaccine-approach-desirable-immune.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Thu, 01 Sep 2011 17:31:33 EST</pubDate>
	 <guid isPermaLink="false">news234117057</guid>
	 
</item>
<item>
     <title>Sugar-binding protein may play a role in HIV infection</title>
   	 <description>Specific types of &quot;helper&quot; T cells that are crucial to maintaining functioning immune systems contain an enzyme called PDI (protein disulfide isomerase).</description>
     <link>http://medicalxpress.com/news/2011-06-sugar-binding-protein-role-hiv-infection.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Tue, 14 Jun 2011 07:45:07 EST</pubDate>
	 <guid isPermaLink="false">news227256222</guid>
	 
</item>


</channel>
</rss>
